Until now, there has not been an optimal way to access marrow for the treatment of cartilage injuries in the foot and ankle. That’s why our team of surgeons and engineers designed SmartShot for the unique challenges of the ankle anatomy. The result: reliable access to cartilage lesions that are difficult to treat with legacy instruments.
Contoured to navigate the talar dome
Enables deep, 6 mm microchannels with only 1 mm diameter
Less disruption of underlying bone allows for improved marrow release and remodeling
See what foot and ankle surgeons have to say about the SmartShot Ankle device.
Micro CT of bone after SmartShot microneedling shows no signs of bony compaction, allowing unrestricted flow of marrow.
A recent peer-revewed independent study provides strong evidence that SmartShot better preserves subchondral bone and minimizes aberrant remodeling after marrow stimulation, compared with K-wire drilling or legacy microfracture. In the study, channels produced by SmartShot produced significantly less bony compaction and improved remodeling postoperatively.
The sooner you get started with the SmartShot ankle device, the sooner your patients can be up and running.